Detalles de la búsqueda
1.
The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study.
Lancet Oncol
; 16(1): 25-35, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25524798
2.
First-line treatment of advanced breast cancer with sunitinib in combination with docetaxel versus docetaxel alone: results of a prospective, randomized phase III study.
J Clin Oncol
; 30(9): 921-9, 2012 Mar 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-22331954
Resultados
1 -
2
de 2
1
Próxima >
>>